Comparison of late dental sequelae in survivors of high-risk neuroblastoma treated with myeloablative high-dose chemotherapy and peripheral blood stem cell transplantation

Key Points

• Late dental sequelae are prevalent in survivors of high-risk neuroblastoma treated with myeloablative high-dose chemotherapy.
• Survivors exhibit significant dental problems, highlighting the need for continuous dental monitoring post-treatment.
• Assessment involved comparing dental health outcomes in individuals after stem cell transplantation.
• Identifying these dental issues underscores the importance of long-term follow-up care for cancer survivors.